GUARDANT360 RESPONSE

Welcome to the Brand page for “GUARDANT360 RESPONSE”, which is offered here for Diagnostic kits consisting primarily of clinical diagnostic reagents and assays for tumor-based cancer detection, monitoring, and treatment;guardant three hundred sixty response guardant thirty six zero response guardant three six zero response;healthcare services, providing a database in the field of cancer related information and featuring inputting and collection of data and information for treatment and diagnostic purposes; medical testing for diagnostic or treatment purposes; providing cancer detection and monitoring services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis, genomic and molecular analysis, and use of bioinformatics tools for cancer detection; providing a website featuring information in the field of cancerous diseases for diagnostic and treatment purposes; providing medical information to healthcare professionals; providing a website featuring information in the field of cancerous diseases for medical purposes;blood collection kit comprised of blood collecting tubes;response;scientific research for medical purposes in the area of cancerous diseases; structural and functional analysis of genomes; providing a website featuring information in the field of cancerous diseases for scientific purposes;.

Its status is currently believed to be active. Its class is unavailable. “GUARDANT360 RESPONSE” is believed to be currently owned by “Guardant Health, Inc.”